TCL Archive Merck Serono Cancels Tecemotide Program In NSCLC, Including Two Phase III Trials September 26, 2014
TCL Archive In Brief: Pretreatment Critical In Antimetic Therapy, Sallan Says; Aging/Cancer Symposium Planned July 11, 1980
TCL Archive In Brief: Kennedy’s Oversight Hearings Will Include Cancer Program, Important To Act Renewal January 26, 1979